Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
986.3 DKK | +0.61% |
|
+0.31% | +41.48% |
06:27am | Novo Nordisk to Meet US Senate Aides Over Levemir Insulin Sales Halt | MT |
Jul. 12 | Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.48% | 636B | |
+62.66% | 854B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.47% | 247B | |
+6.01% | 230B | |
+18.53% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk to Meet US Senate Aides Over Levemir Insulin Sales Halt